Crestor Tops List of Best-Selling Drugs
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 5, 2013 Category: Journals (General) Source Type: news
Crestor Tops List of Best-Selling Drugs
Title: Crestor Tops List of Best-Selling DrugsCategory: Health NewsCreated: 11/2/2013 11:00:00 AMLast Editorial Review: 11/4/2013 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - November 4, 2013 Category: Cardiology Source Type: news
Crestor Tops List of Best-Selling Drugs
The cholesterol-lowering drug Crestor (rosuvastatin) was the nation's most prescribed drug in the past 12 months, according to a new report from research firm IMS Health. (Source: WebMD Health)
Source: WebMD Health - November 1, 2013 Category: Consumer Health News Source Type: news
Top 100 Selling Drugs Through September ReportedTop 100 Selling Drugs Through September Reported
Cholesterol-lowering rosuvastatin was the nation's most prescribed drug over the course of the last 12 months through September, and the antipsychotic aripiprazole racked up the highest sales. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 31, 2013 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news
McSweeney / Langevin Providing Legal Advice in Response to Alleged...
The law firm McSweeney / Langevin is investigating Type 2 Diabetes claims allegedly caused by the cholesterol-lowering drugs Lipitor, Zocor, and Crestor. McSweeney / Langevin's legal investigation...(PRWeb October 11, 2013)Read the full story at http://www.prweb.com/releases/2013/10/prweb11218941.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 14, 2013 Category: Pharmaceuticals Source Type: news
Statin Thwarts Contrast-Induced Renal Injury (CME/CE)
(MedPage Today) -- Both low and high doses of rosuvastatin (Crestor) reduced the risk of contrast-induced acute kidney injury in high-risk patients in the catheterization lab and improved short-term clinical outcomes, two randomized trials showed. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 9, 2013 Category: Cardiology Source Type: news
Statin Drugs May Increase Risk Of Diabetes
Certain statins - also known as cholesterol-lowering medications - could increase your risk of developing type 2 diabetes, a new study suggests. The risk was most significant in patients taking atorvastatin (Lipitor), rosuvastatin (Crestor) and simvastatin (Zocor), according to the study, published in BMJ. Statins are the most widely prescribed medications for the prevention of cardiovascular events. Generally, these medications are well received, however, a new link to diabetes has been suggested. Previous studies have indicated a 27% elevated risk of diabetes with rosuvastatin... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 24, 2013 Category: Consumer Health News Tags: Statins Source Type: news
Risk of Diabetes With Statins Risk of Diabetes With Statins
While one study is reassuring for older patients treated with statins, with researchers finding no evidence of an increased risk of diabetes in acute coronary syndrome patients, the other suggests that the more potent statins, such as rosuvastatin, atorvastatin, and simvastatin, do pose an increased risk compared with pravastatin. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 24, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news
Two studies address diabetes risks with statins—one good news, one so-so
While one study is reassuring for older patients treated with statins, with researchers finding no evidence of an increased risk of diabetes in acute coronary syndrome patients, the other suggests that the more potent statins, such as rosuvastatin, atorvastatin, and simvastatin, do pose an increased risk compared with pravastatin. (Source: theHeart.org)
Source: theHeart.org - May 23, 2013 Category: Cardiology Source Type: news
AstraZeneca hit by generic drugs and Crestor shortfall
LONDON (Reuters) - AstraZeneca's sales fell by a bigger-than-expected 13 percent in the first quarter as patent expiries took a heavy toll, underscoring the turnaround challenge facing Britain's second-largest drugmaker. (Source: Reuters: Health)
Source: Reuters: Health - April 25, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
High-dose statins 'raise risk of serious kidney problems'
High-dose statins taken by millions of people are putting them at increased risk of potentially fatal kidney problems, researchers are warning. (Source: Telegraph Health)
Source: Telegraph Health - March 20, 2013 Category: Consumer Health News Tags: rosustatin kidney simvastatin AKI lipitor atorvastatin crestor Source Type: news
New Analysis Finds CRP Testing Followed by Rosuvastatin Therapy Cost-Effective
Researchers show that test and treat approach for C-reactive protein appears cost-effective; it also has the potential to be cost-saving. (Source: BWH News)
Source: BWH News - February 7, 2011 Category: Hospital Management Source Type: news
